Literature DB >> 25823431

Regional radiotherapy in high-risk breast cancer: is the issue solved?

M Krause1,2,3,4, C Petersen5, B V Offersen6, M Baumann1,2,3,4.   

Abstract

Adjuvant radiotherapy is the treatment standard for breast cancer with lymph node metastases after breast-conserving surgery or mastectomy. The inclusion of regional lymph nodes into the treatment volumes has been a question in recent clinical trials. Their impact on treatment standards and open questions is discussed.

Entities:  

Mesh：

Year:  2015        PMID： 25823431      PMCID： PMC4628532          DOI： 10.1259/bjr.20150071

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  8 in total

1.  CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects.

Authors:  Lise B J Thorsen; Mette S Thomsen; Martin Berg; Ingelise Jensen; Mirjana Josipovic; Marie Overgaard; Jens Overgaard; Peter Skogholt; Birgitte V Offersen
Journal:  Acta Oncol       Date:  2014-06-24       Impact factor: 4.089

2.  DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways.

Authors:  M-L Sautter-Bihl; F Sedlmayer; W Budach; J Dunst; P Feyer; R Fietkau; C Fussl; W Haase; W Harms; M D Piroth; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

3.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Authors:  Mila Donker; Geertjan van Tienhoven; Marieke E Straver; Philip Meijnen; Cornelis J H van de Velde; Robert E Mansel; Luigi Cataliotti; A Helen Westenberg; Jean H G Klinkenbijl; Lorenzo Orzalesi; Willem H Bouma; Huub C J van der Mijle; Grard A P Nieuwenhuijzen; Sanne C Veltkamp; Leen Slaets; Nicole J Duez; Peter W de Graaf; Thijs van Dalen; Andreas Marinelli; Herman Rijna; Marko Snoj; Nigel J Bundred; Jos W S Merkus; Yazid Belkacemi; Patrick Petignat; Dominic A X Schinagl; Corneel Coens; Carlo G M Messina; Jan Bogaerts; Emiel J T Rutgers
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

4.  Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.

Authors:  Marie Overgaard; Hanne M Nielsen; Jens Overgaard
Journal:  Radiother Oncol       Date:  2007-02-15       Impact factor: 6.280

5.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

6.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Authors:  Viviana Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra; Oreste Gentilini; Mauro G Mastropasqua; Giovanni Mazzarol; Samuele Massarut; Jean-Rémi Garbay; Janez Zgajnar; Hanne Galatius; Angelo Recalcati; David Littlejohn; Monika Bamert; Marco Colleoni; Karen N Price; Meredith M Regan; Aron Goldhirsch; Alan S Coates; Richard D Gelber; Umberto Veronesi
Journal:  Lancet Oncol       Date:  2013-03-11       Impact factor: 41.316

7.  Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.

Authors:  Christophe Hennequin; Nadine Bossard; Stéphanie Servagi-Vernat; Philippe Maingon; Jean-Bernard Dubois; Jean Datchary; Christian Carrie; Bernard Roullet; Jean-Philippe Suchaud; Eric Teissier; Audrey Lucardi; Jean-Pierre Gerard; Aurélien Belot; Jean Iwaz; René Ecochard; Pascale Romestaing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-09       Impact factor: 7.038

8.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

Authors:  P McGale; C Taylor; C Correa; D Cutter; F Duane; M Ewertz; R Gray; G Mannu; R Peto; T Whelan; Y Wang; Z Wang; S Darby
Journal:  Lancet       Date:  2014-03-19       Impact factor: 79.321
  8 in total
  1 in total

Review 1.  Axillary irradiation omitting axillary dissection in breast cancer: is there a role for shoulder-sparing proton therapy?

Authors:  P Farace; M A Deidda; M Amichetti
Journal:  Br J Radiol       Date:  2015-07-08       Impact factor: 3.039
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.